A QMSR gap analysis is one of the most important steps medical device manufacturers can take to ensure compliance with the FDA’s Quality Management System Regulation. By systematically comparing your current quality system against QMSR requirements, you can identify deficiencies before they become regulatory findings during an FDA inspection. Understanding the QMSR Gap Analysis A gap analysis is a…
With the FDA QMSR now in effect, conducting a thorough readiness assessment is critical for medical device manufacturers who want to ensure their quality systems meet the new regulatory requirements. A QMSR readiness assessment goes beyond a simple documentation review — it evaluates whether your organization’s quality management system is fully aligned with the combined requirements of ISO 13485:2016…
The FDA’s Quality Management System Regulation became effective on February 2, 2026, marking the end of a two-year transition period and the beginning of a new era in medical device quality regulation. Understanding the timeline, current requirements, and what to expect going forward is essential for every medical device manufacturer. The QMSR Timeline The journey to QMSR began years…
With the FDA QMSR now in effect as of February 2, 2026, medical device manufacturers face a new regulatory reality. Compliance is no longer optional, and the FDA has already begun conducting inspections under the new framework. Here is what you need to know to ensure your organization is prepared. The Compliance Deadline Has Passed Unlike some regulatory transitions…
The FDA Quality Management System Regulation (QMSR) represents the most significant change to medical device quality system requirements in the United States in decades. Effective February 2, 2026, the QMSR replaces the legacy Quality System Regulation (QSR) under 21 CFR Part 820 by incorporating ISO 13485:2016 by reference. What Is the QMSR? The QMSR is the FDA’s effort to…
